We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Evotec to Strengthen its Compound Collection Through a Collaboration with ChemBridge
News

Evotec to Strengthen its Compound Collection Through a Collaboration with ChemBridge

Evotec to Strengthen its Compound Collection Through a Collaboration with ChemBridge
News

Evotec to Strengthen its Compound Collection Through a Collaboration with ChemBridge

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Evotec to Strengthen its Compound Collection Through a Collaboration with ChemBridge"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Evotec AG has announced that it has entered into a collaboration with ChemBridge, to further enhance its screening library. This collaboration demonstrates Evotec’s continued improvement to its industry leading hit identification platform.

Evotec’s library of 250,000 drug-like and lead-like compounds is available to clients for screening and differentiated itself from other screening libraries through quality, diversity and novelty.

Through this collaboration, Evotec will increase its high throughput screening collection through the addition of initially 110,000 diverse and lead-like compounds from the ChemBridge Library Collection. These new compounds complement the chemical diversity of Evotec’s existing collection and will further enhance the quality of the hits provided to our partners.

Dr Mario Polywka, Chief Operating Officer at Evotec stated: “We are happy to partner with ChemBridge on the expansion of Evotec’s high throughput screening collection. This collaboration coupled with our continued investment in our world leading, hit-identification platform will allow Evotec to maintain our market leadership and continue to provide high quality hit compounds to our clients.”

Mr. Eugene Vaisberg, Chief Executive Officer at Chembridge, commented: “We are pleased to have this opportunity to work with Evotec. This alliance will allow ChemBridge to expand the reach of its renowned small molecule screening library via Evotec’s industry leading hit- identification platform.”

Advertisement